BioPharma Dive - Latest News

New genetic medicine CDMO acquires Landmark Bio

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene and cell therapies.

Apr 2, 2025 - 17:21
 0
New genetic medicine CDMO acquires Landmark Bio

Artis BioSolutions joins a host of startups trying to improve development and manufacturing capacity for cutting-edge gene and cell therapies.

Read More

Tags:

Previous Article

One&Only Expands Portfolio with Private Homes Rental Initiative

Next Article

Harry’s resets brand with push beyond product-focused marketing

Related Posts

Immune drugmakers Alumis and Acelyrin to merge

Immune drugmakers Alumis and Acelyrin to merge

Feb 9, 2025  0

How biotech and pharma teams are reaching LPI ahead of schedule

How biotech and pharma teams are reaching LPI ahead of ...

Mar 17, 2025  0

‘It’s not for the faint of heart.’ How 3 CEOs took their biotechs public

‘It’s not for the faint of heart.’ How 3 CEOs took thei...

Feb 14, 2025  0